In the news: Avastin first biologic backed in EU for resistant ovarian cancer

Good news about Avastin, however it will be some time before this indication appears on the Cancer Drugs Fund listing.

Read full story here:

For information, advice and support please contact us on 02072996650 or email

Best wishes,

The Ovacome Team.

1 Reply

  • I am extremely lucky to be in an area it is approved and used in. Have been on it since October 2013 and numbers are still falling. Long may it last. It does have side effects, mine are aches in the area of the tumour from time to time especially if I am tired and a runny nose and aches and pains but nothing that cant be resolved by paracetamol. My bp is normal although I had been on medication prior to starting treatment In all I have to say am pleased its doing what it says on the tin

You may also like...